https://biotechmorning.com/news/tecartus-first-car-t-full-fda-approval-mcl Biotech Morning en 2026-04-04T14:09:01.986Z Tecartus Just Became the First CAR-T to Graduate From Accelerated Approval https://biotechmorning.com/news/syneron-bio-250m-four-months-series-b Biotech Morning en 2026-04-04T14:08:20.614Z $250M in Four Months: The Beijing Startup Big Pharma Can't Stop Funding https://biotechmorning.com/news/gilead-weekly-hiv-pill-terminated-safety Biotech Morning en 2026-04-04T14:07:35.012Z Gilead's Weekly HIV Pill Was Supposed to Change Everything. Then It Backfired. https://biotechmorning.com/news/400-billion-bluff-pharma-tariff-escape-hatch Biotech Morning en 2026-04-04T14:06:57.227Z Inside Big Pharma's Tariff Escape Hatch https://biotechmorning.com/news/white-house-hhs-budget-cut-fy2027-biotech Biotech Morning en 2026-04-04T14:06:16.401Z The $15 Billion Question Hanging Over Biotech's Future https://biotechmorning.com/news/biopharma-pipeline-shrinks-first-time-30-years Biotech Morning en 2026-04-04T14:05:31.561Z The Drug Pipeline Just Shrank for the First Time in 30 Years https://biotechmorning.com/news/syneron-bio-150m-peptide-platform Biotech Morning en 2026-04-03T14:23:19.592Z The Peptide Startup That Just Raised More Than Most Biotechs Are Worth https://biotechmorning.com/news/beam-base-editing-sickle-cell-nejm Biotech Morning en 2026-04-03T14:22:37.143Z The Gene Editor That Rewrites DNA Like a Pencil Just Aced Its Biggest Test https://biotechmorning.com/news/lilly-oral-obesity-pill-fda-approval Biotech Morning en 2026-04-03T14:19:56.945Z Lilly Just Made the Obesity Pill You Don't Need a Needle For https://biotechmorning.com/news/spinraza-high-dose-biogen-sma-fda-approval Biotech Morning en 2026-04-03T14:15:13.429Z Spinraza's Second Act: How a Higher Dose Could Save Biogen's Biggest Franchise https://biotechmorning.com/news/uk-us-pharma-tariff-deal Biotech Morning en 2026-04-03T14:11:10.020Z The UK Just Got a Hall Pass From America's Pharma Tariff Apocalypse https://biotechmorning.com/news/100-percent-tariff-pharma-imports Biotech Morning en 2026-04-03T14:10:24.366Z The 100% Tariff That Could Reshape How America Gets Its Drugs